相似文献
1
Consensus statement on management of dyslipidemia in Indian subjects.
Indian Heart J. 2014 Dec;66 Suppl 3(Suppl 3):S1-51. doi: 10.1016/j.ihj.2014.12.001. Epub 2014 Dec 24.
2
The Lipid Association of India (LAI) Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: A Giant Leap Forward!
J Assoc Physicians India. 2016 Jun;64(6):102.
3
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India.
J Clin Lipidol. 2023 Mar-Apr;17(2):e1-e14. doi: 10.1016/j.jacl.2022.11.002. Epub 2022 Nov 23.
4
Consensus statement on the management of dyslipidaemias in adults.
Diabetes Metab. 2016 Dec;42(6):398-408. doi: 10.1016/j.diabet.2016.07.033. Epub 2016 Sep 20.
5
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research.
Indian Heart J. 2022 Sep-Oct;74(5):341-350. doi: 10.1016/j.ihj.2022.07.009. Epub 2022 Aug 5.
6
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2020: Part III.
J Assoc Physicians India. 2020 Nov;68(11[Special]):8-9.
7
Consensus statement on the management of dyslipidaemias in adults.
Ann Endocrinol (Paris). 2017 Feb;78(1):43-53. doi: 10.1016/j.ando.2016.11.001. Epub 2017 Jan 12.
8
CSI clinical practice guidelines for dyslipidemia management: Executive summary.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S6-S19. doi: 10.1016/j.ihj.2023.11.271. Epub 2023 Dec 4.
9
Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.
Am J Med Sci. 2016 Apr;351(4):361-5. doi: 10.1016/j.amjms.2016.01.020. Epub 2016 Feb 2.
10
Managing Dyslipidemia in Type 2 Diabetes.
Endocrinol Metab Clin North Am. 2018 Mar;47(1):153-173. doi: 10.1016/j.ecl.2017.10.004. Epub 2017 Dec 20.
引用本文的文献
1
Evaluation of Lipid Profile Management in Coronary Artery Disease Patients on Statin Therapy: A Single-Centre, Retrospective, Observational Study.
Cureus. 2024 Oct 20;16(10):e71942. doi: 10.7759/cureus.71942. eCollection 2024 Oct.
2
Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease.
Ann Card Anaesth. 2024 Jan 1;27(1):32-36. doi: 10.4103/aca.aca_88_23. Epub 2024 Jan 12.
3
Functionality and Health-Promoting Properties of Polysaccharide and Plant-Derived Substances from .
Foods. 2024 Apr 8;13(7):1134. doi: 10.3390/foods13071134.
4
Exercise and lipids.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S73-S74. doi: 10.1016/j.ihj.2023.11.270. Epub 2024 Apr 8.
5
Profile of type 2 diabetes mellitus patients attending family medicine clinic in a rural tribal locality in India.
J Family Med Prim Care. 2023 Dec;12(12):3242-3248. doi: 10.4103/jfmpc.jfmpc_2114_22. Epub 2023 Dec 21.
6
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
PLOS Glob Public Health. 2024 Feb 12;4(2):e0002905. doi: 10.1371/journal.pgph.0002905. eCollection 2024.
7
Content and quality of clinical practice guidelines for the management of type 2 diabetes in India: A systematic review.
Endocrinol Diabetes Metab. 2023 Mar;6(2):e405. doi: 10.1002/edm2.405. Epub 2023 Jan 16.
8
Quality of the Indian clinical practice guidelines for the management of cardiovascular conditions.
JRSM Open. 2022 Dec 5;13(12):20542704221127178. doi: 10.1177/20542704221127178. eCollection 2022 Dec.
9
Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study.
Diabetol Metab Syndr. 2022 Sep 26;14(1):137. doi: 10.1186/s13098-022-00907-9.
10
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research.
Indian Heart J. 2022 Sep-Oct;74(5):341-350. doi: 10.1016/j.ihj.2022.07.009. Epub 2022 Aug 5.
本文引用的文献
1
Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: a study in patients with first myocardial infarction.
Indian Heart J. 2014 Nov-Dec;66(6):580-6. doi: 10.1016/j.ihj.2014.10.399. Epub 2014 Nov 10.
2
Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2789-94. doi: 10.1016/j.jacc.2014.04.010. Epub 2014 May 7.
3
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).
Heart. 2014 Apr;100 Suppl 2:ii1-ii67. doi: 10.1136/heartjnl-2014-305693.
4
Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS).
J Assoc Physicians India. 2013 Feb;61(2):97-101.
5
Standards of medical care in diabetes--2014.
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014.
6
Statins: new American guidelines for prevention of cardiovascular disease.
Lancet. 2013 Nov 30;382(9907):1762-5. doi: 10.1016/S0140-6736(13)62388-0. Epub 2013 Nov 20.
7
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
8
Soy fiber improves weight loss and lipid profile in overweight and obese adults: a randomized controlled trial.
Mol Nutr Food Res. 2013 Dec;57(12):2147-54. doi: 10.1002/mnfr.201300159. Epub 2013 Jul 23.
9
Pioglitazone: A prudent prescription.
Indian J Endocrinol Metab. 2013 May;17(3):370-2. doi: 10.4103/2230-8210.111594.
10
Dietary intakes and familial correlates of overweight/obesity: a four-cities study in India.
Ann Nutr Metab. 2013;62(4):279-90. doi: 10.1159/000346554. Epub 2013 May 16.
Zotero 插件